Chronic and treatment refractory cases of panic disorder are not uncommon. We report on a man completely remitted from panic disorder after olanzapine and paroxetine combined treatment, and the possible modulating anti-anxiety effect of olanzapine is discussed. Olanzapine augmentation in panic and other anxiety disorders is deserving of more clinical attention.
References
-
1
Etxebeste M, Aragues E, Malo P, Pacheco L.
Olanzapine and panic attacks.
Am J Psychiatry.
2000 Apr;
157(4)
659-60
-
2
Mathew S J, Coplan J D, Gorman J M.
Management of treatment-refractory panic disorder.
Psychopharmacol Bull.
2001 Spring;
35(2)
97-110
-
3
Nyberg S, Farde L, Halldin C.
A PET study of 5-HT2 and D2 dopamine receptor occupancy induced by olanzapine in healthy subjects.
Neuropsychopharmacology.
1997;
16
1-7
-
4
Roy-Byrne P P, Cowley D S.
Course and outcome in panic disorder: a review of recent follow-up studies.
Anxiety.
1994 - 1995;
1(4)
151-60
-
5
Shelton R C, Tollefson G D, Tohen M ,. et al .
A novel augmentation strategy for treating resistant major depression.
Am J Psychiatry.
2001;
158
31-134
-
6
Work Group on Panic D isorder, American Psychiatric A ssociation.
Practice guideline for the treatment of patients with panic disorder.
Am J Psychiatry.
1998 May;
155(5 Suppl)
1-34
Iou-Lin Chao, M.D.
Department of Psychiatry
Taipei Veteran’s General Hospital
Taipei
Taiwan
Email: ilchao@vghtpe.gov.tw
